Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:TXAC

Nkarta (TXAC) Stock Price, News & Analysis

About Nkarta Stock (NASDAQ:TXAC)

Key Stats

Today's Range
N/A
50-Day Range
$12.81
$15.49
52-Week Range
N/A
Volume
N/A
Average Volume
37,676 shs
Market Capitalization
$189.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Therapeutics Acquisition Corp. focuses on merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify and acquire a business focusing on the healthcare industry. The company was founded in 2020 and is based in Boston, Massachusetts.

Receive TXAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nkarta and its competitors with MarketBeat's FREE daily newsletter.

TXAC Stock News Headlines

Best Internet Providers in Houston, Texas
Wichita Falls, TX
25X predicted for “Amazon Coin” – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024
Nkarta, Inc. (NKTX)
Beaumont, TX
How Much Does an LLC Cost in Texas? (2024 Filing Fees)
See More Headlines

TXAC Stock Analysis - Frequently Asked Questions

Nkarta (TXAC) raised $100 million in an initial public offering on Wednesday, July 8th 2020. The company issued 10,000,000 shares at a price of $10.00 per share. Jefferies served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nkarta investors own include XPeng (XPEV), Puma Biotechnology (PBYI), Outlook Therapeutics (OTLK), Nkarta (NKTX), NovaBay Pharmaceuticals (NBY), Lyra Therapeutics (LYRA) and Heron Therapeutics (HRTX).

Industry, Sector and Symbol

Sector
N/A
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NASDAQ:TXAC
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$189.83 million
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (NASDAQ:TXAC) was last updated on 11/25/2024 by MarketBeat.com Staff
From Our Partners